0
World
With Canada approving 1st generic semaglutide, how will costs compare?
April 29, 2026
Scroll
Posted 3 hours ago by
Manufactured by Dr. Reddy’s Laboratories in India, the injectable medication has been approved for once-a-week treatment of Type 2 diabetes in adults.
Global News
Coverage and analysis from Canada. All insights are generated by our AI narrative analysis engine.
Canada
Bias: center
People's Voices (0)
Leave a comment
0/500
Note: Comments are moderated. Please keep it civil. Max 3 comments per day.